Two Days That Mapped the Next Phase of APAC Dealmaking

Singapore, Sept. 2 -- EVENT WRAP-UP | ASIA BIO PARTNERING FORUM 2026 A forum that met the moment Some conferences describe the industry. The better ones hold a mirror up to it at exactly the right t... Read More

China's Simcere Zaiming signs $1.5 B deal with Roche for SIM0660 global development

Singapore, Sept. 2 -- Simcere Zaiming, a subsidiary of China-based Simcere Pharmaceutical Group, has entered into an exclusive global licensing agreement with Roche for the development and commerciali... Read More

Korea's GC Biopharma collaborates with French firm Osivax to develop next-gen influenza vaccine

Singapore, Sept. 1 -- Osivax, a France based clinical-stage biopharmaceutical company developing differentiated influenza vaccines designed to generate broad-spectrum immune responses, and GC Biopharm... Read More

The New APAC Healthcare Equation: Innovation, Capital, AI and Global Scale

Singapore, Sept. 1 -- The most useful thing about an opening plenary is usually not what gets said. It is who the organisers decided to put on stage. The fourth edition of the Asia Bio Partnering For... Read More

Five Allocators, No Founders: What the Asia Bio Dealmaking Panel Was Really Pricing

Singapore, Sept. 1 -- A session billed as a conversation about partnering was, on closer inspection, something rather more useful: a pricing signal, delivered by the only people in the room who set pr... Read More

Fosun Pharma strengthens innovation pipeline as Henlius and global drug portfolio expand

Singapore, Aug. 31 -- Fosun Pharma continued to strengthen its innovation-led growth strategy in the first half of 2026, supported by increasing contributions from innovative drugs, pipeline progress ... Read More

CanSinoBIO accelerates overseas growth as vaccine portfolio and mRNA pipeline expand

Singapore, Aug. 31 -- CanSino Biologics reported continued momentum in its international business during the first half of 2026, alongside progress across its marketed vaccines, regulatory-stage produ... Read More

DualityBio and Genentech partner on next-generation ADCs in deal worth over $1 billion

Singapore, Aug. 31 -- Shanghai-based DualityBio has entered a global collaboration and licensing agreement with Genentech to develop next-generation antibody-drug conjugates using its proprietary DUPA... Read More

Formosa Pharma files European trial application for Kadcyla biosimilar TSY-110

Singapore, Aug. 31 -- Taiwan-based Formosa Pharmaceuticals has submitted a Clinical Trial Application to European regulators for a pivotal study of TSY-110, its biosimilar candidate referencing the HE... Read More

Novogene to establish first Australian genomics laboratory at Cabrini Health

Singapore, Aug. 28 -- Global multi-omics leader Novogene is establishing its first Australian laboratory at Cabrini Health, bringing advanced genomic capabilities closer to Australian patients and res... Read More

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»